Leukemia, Lymphoid: all 1,772 studies
Page 12 of 18. Open to participants first (173), then studies with results posted, then the rest; newest registration first within each.
- CPI-613, Bendamustine Hydrochloride, and Rituximab in Treating Patients With Relapsed or Refractory B-Cell Non-Hodgkin LymphomaTerminatedNCT02168907Phase 1
- CPI-613 and Bendamustine Hydrochloride in Treating Patients With Relapsed or Refractory T-Cell Non-Hodgkin Lymphoma or Hodgkin LymphomaCompletedNCT02168140Phase 1
- Study of Efficacy and Safety of CTL019 in Adult ALL PatientsWithdrawnNCT02167360Phase 2
- Observational Study of Low Dose FCR in Elderly/Comorbid CLL/SLL: The Q-lite ProjectStatus unknownNCT02156726
- An Open-Label, Single-Arm, Multicenter Pharmacokinetic Study of Intramuscular Erwinaze® (Asparaginase Erwinia Chrysanthemi)/Erwinase® (Crisantaspase)WithdrawnNCT02150928Phase 2
- Pretreatment With Valproate Prior to Immunotherapy Targeting Cluster of Differentiation Antigen 20 in Chronic Lymphocytic LeukemiaCompletedNCT02144623Early Phase 1
- Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of VAY736 in Relapsed or Refractory CLL PatientsTerminatedNCT02137889Phase 1
- Expanded Access for Idelalisib in Combination With Rituximab in Chronic Lymphocytic LeukemiaApproved for marketingNCT02136511
- Targeted Marrow Irradiation, Fludarabine Phosphate, and Busulfan Before Donor Progenitor Cell Transplant in Treating Patients With Hematologic MalignanciesCompletedNCT02129582Phase 1
- Organ-Sparing Marrow-Targeted Irradiation Before Stem Cell Transplant in Treating Patients With High-Risk Hematologic MalignanciesCompletedNCT02122081Phase 1
- Exergaming Intervention in ALL PatientsCompletedNCT02118324Not applicable
- Clinical Study of Relapsed/Refractory Chronic Lymphocytic Leukemia (CLL)SuspendedNCT02117336Phase 1
- Ribomustin in the First Line Therapy of Chronic Lymphocytic LeukemiaCompletedNCT02110394
- Ibrutinib in Treating Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma in Patients With HIV InfectionTerminatedNCT02109224Phase 1
- TGR-1202, a PI3K Delta Inhibitor, in Combination With Obinutuzumab and Chlorambucil in Patients With Chronic Lymphocytic Leukemia (CLL)CompletedNCT02100852Phase 1
- Fludarabine Phosphate, Clofarabine, and Busulfan With Vorinostat in Treating Patients With Acute Leukemia in Remission or Relapse Undergoing Donor Stem Cell TransplantCompletedNCT02083250Phase 1
- A Phase I Study of Oral Asciminib (ABL001) in Patients With CML or Ph+ ALLCompletedNCT02081378Phase 1
- An Observational Study Examining the Effect of Added MabThera Therapy in Patients With Untreated Chronic Lymphocytic LeukemiaCompletedNCT02080884
- Phase III Study of Vincristine Sulfate Liposome For Injection In Adults With Naïve Acute Lymphoblastic LeukemiaStatus unknownNCT02072785Phase 3
- Pegylated Liposomal Doxorubicin Versus Daunorubicin to Treat Acute Lymphoblastic Leukemia:Status unknownNCT02070523Phase 3
- MRD/Risk-oriented Therapy of Adult Ph- ALL Including Pegylated Asparaginase and Lineage-targeted MethotrexateCompletedNCT02067143Phase 2
- Targeted Busulfan, Fludarabine, Etoposide Conditioning Regimen for HSCT in Childhood and Adolescent ALL.Status unknownNCT02047578Phase 2
- A Pilot Study of Allopurinol As A Modifier of 6-MP Metabolism in Pediatric ALLCompletedNCT02046694Early Phase 1
- Chemotherapy With Liposomal Cytarabine CNS Prophylaxis for Adult Acute Lymphoblastic Leukemia & Lymphoblastic LymphomaTerminatedNCT02043587Phase 2
- Haplo-identical HSCT Versus Chemotherapy for Adult Acute Lymphoblastic Leukemia PatientsCompletedNCT02042690Phase 3
- Safety, Tolerability Study of SG2000 in the Treatment of Advanced Chronic Lymphocytic Leukemia and Acute Myeloid LeukemiaTerminatedNCT02034227Phase 1/2
- IPI-145 in Relapsed Refractory Acute Lymphoblastic Leukemia (ALL)WithdrawnNCT02028039Phase 2
- Evaluation of Splenic Irradiation in Chronic Lymphatic LeukemiaWithdrawnNCT02020109
- Ruxolitinib in the Treatment of Chronic Lymphocytic LeukemiaCompletedNCT02015208Phase 1/2
- Retrospective Analysis of Survival in Adult MRD Positive Acute Lymphoblastic Leukemia PatientsCompletedNCT02010931
- Historical Data Analysis of Hematological Remission and Survival in Adults With R/R Acute Lymphoblastic LeukemiaCompletedNCT02003612
- A Study of GDC-0853 in Patients With Resistant B-Cell Lymphoma or Chronic Lymphocytic Leukemia.CompletedNCT01991184Phase 1
- Treatment Protocol of Children With Philadelphia Chromosome Negative High Risk Acute Lymphoblastic LeukemiaStatus unknownNCT01990807Phase 4
- Phase II Clinical Trial of Alemtuzumab to Treat B-cell Chronic Lymphocytic LeukemiaSuspendedNCT01982175Phase 2
- Vaccine Therapy for Treating Patients With Previously Untreated Chronic Lymphocytic Leukemia (CLL)Status unknownNCT01976520Phase 1
- Pilot Study of Redirected Haploidentical Natural Killer Cell Infusions for B-Lineage Acute Lymphoblastic LeukemiaSuspendedNCT01974479Phase 1
- AZD6738 First Time in Patient Multiple Ascending Dose StudyCompletedNCT01955668Phase 1
- Childhood Acute Lymphoblastic Leukemia Treatment Protocol Moscow-Berlin 2008Status unknownNCT01953770Not applicable
- Hyper-CVAD Treatment of Adult T-cell Acute Lymphoblastic Leukemia in Sweden.CompletedNCT01950286
- Salvage Therapy With Chemotherapy and Natural Killer Cells in Relapsed/Refractory Paediatric T Cell Lymphoblastic Leukaemia and LymphomaTerminatedNCT01944982Phase 1/2
- Phase II Study of Vismodegib in Patients With Refractory or Relapsed B-cell Lymphoma or Chronic Lymphocytic LeukemiaTerminatedNCT01944943Phase 2
- Phase I/II Study of Nilotinib/Ruxolitinb Therapy for TKI Resistant Ph-LeukemiaCompletedNCT01914484Phase 1/2
- L-asparaginase Encapsulated in Red Blood Cells (Eryaspase) for Treatment of Adult Patients With ALL or LBLTerminatedNCT01910428Phase 1
- Study on Two Different Formulations of 6-mercaptopurine. Tablet Versus Oral LiquidStatus unknownNCT01906671Phase 4
- Renal and Hepatic Clearance Following High-Dose Methotrexate in Childhood ALLCompletedNCT01896752
- Pneumococcal Vaccine in Untreated CLL PatientsCompletedNCT01892618Phase 3
- Study of Moxetumomab Pasudotox in Patients With Relapsed and/or Refractory Acute Lymphoblastic Leukemia (ALL)TerminatedNCT01891981Phase 1
- Lenalidomide and Ibrutinib in Treating Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic LymphomaCompletedNCT01886859Phase 1
- The Influence of Thiopurine Methyltransferase Activity on Toxicity After High-dose Methotrexate in Childhood Acute Lymphoblastic LeukemiaCompletedNCT01886651
- TKI Therapy Based on Molecular Monitoring in Allogeneic-HSCT Recipients With Philadelphia Chromosome-positive Acute Lymphoblastic LeukemiaStatus unknownNCT01883219Phase 2
- HD-Idarubicin/Etoposide Intensified Conditioning Regimen Allo-HSCT for Adult ALLStatus unknownNCT01873807Phase 4
- Study of IPI-145 in Combination With Rituximab or Bendamustine/Rituximab in Hematologic MalignanciesCompletedNCT01871675Phase 1
- Treatment of Relapsed and/or Chemotherapy Refractory B-cell Malignancy by CART19Status unknownNCT01864889Not applicable
- Eradication of Residual Disease by Preemptive Immunointervention After Allogeneic Hematopoietic Stem Cells Transplantation in Chronic Lymphocytic LeukemiaStatus unknownNCT01849939Phase 2
- A Phase 1 Study of Novel GS-9973 Tablet Formulations to Evaluate the Effect of Acid Reducing Agents, Relative Bioavailability, and Food Effect on GS-9973 PharmacokineticsCompletedNCT01841489Phase 1
- BR in Patients With CLL With Comorbidities and/or Renal DysfunctionCompletedNCT01832922Phase 1
- Trial to Assess the Efficacy of a TCR Alfa Beta Depleted Graft in Pediatric Affected by ALL or AML and Receiving an HSCTCompletedNCT01810120Phase 1/2
- Ofatumumab Induction and Maintenance in Elderly Patients With Poor Risk CLL in the Context of Allogeneic TransplantationCompletedNCT01809847Phase 2
- A Phase I Trial of DI-B4 in Patients With Advanced CD19 Positive Indolent B-cell MalignanciesCompletedNCT01805375Phase 1
- Safety and Efficacy Study of Donor Natural Killer Cells Given After Haploidentical Hematopoietic Cell TransplantationCompletedNCT01795378Phase 1/2
- A Safety Study of SGN-CD19A for Leukemia and LymphomaCompletedNCT01786096Phase 1
- Retrospective Evaluation of the Clinical Results Obtained in Patients With Acute Lymphoblastic Leukemia Treated at the San Giovanni Battista Hospital.Status unknownNCT01785914
- Effect of Bovine Colostrum on Toxicity and Inflammatory ResponsesCompletedNCT01766804Not applicable
- Assessment of Efficacy and Safety of Front-line Fludarabine, Cyclophoshamide and Ofatumumab Chemoimmunotherapy in Young Patients With Chronic Lymphocytic Leukemia.CompletedNCT01762202Phase 2
- Acute Lymphoblastic Leukemia Registry at Asan Medical CenterTerminatedNCT01761682
- Phase II Study of Bendamustine and Rituximab Induction Chemoimmunotherapy Followed by Maintenance Rituximab (Rituxan®) and Lenalidomide (Revlimid®) in Relapsed and Refractory Chronic Lymphocytic Leukemia (CLL) and Small Lymphocytic Lymphoma (SLL)WithdrawnNCT01754870Phase 2
- Comparison Between Cyclophosphamide and Combination of Methotrexate + Calcineurin Inhibitor for GVHD ProphylaxisTerminatedNCT01749111Phase 3
- Safety Study of CC-292 and Rituximab in Subjects With Chronic Lymphocytic Leukemia/Small Lymphocytic LymphomaCompletedNCT01744626Phase 1
- A Study of Safety and Effectiveness of Bendamustine Hydrochloride in Adult Filipino Patients With Chronic Lymphocytic LeukemiaWithdrawnNCT01739491
- Genetically Engineered Lymphocyte Therapy in Treating Patients With Lymphoma That is Resistant or Refractory to ChemotherapyStatus unknownNCT01735604Phase 1/2
- Safety Study of CC-292 and Lenalidomide in Subjects With Chronic Lymphocytic Leukemia/ Small Lymphocytic LymphomaCompletedNCT01732861Phase 1
- Phase I Dose Escalation Study of IMMU-114 in Relapsed or Refractory NHL and CLLTerminatedNCT01728207Phase 1
- Study of Frontline Dasatinib Plus Chemotherapy in Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia (PH+ALL)CompletedNCT01724879Phase 2
- Fludarabine/Rituximab Combined With Escalating Doses of Lenalidomide in Untreated CLLCompletedNCT01703364Phase 1/2
- Phase 1 Study of TG02 Citrate in Patients With Chronic Lymphocytic Leukemia and Small Lymphocytic LymphomaCompletedNCT01699152Phase 1
- Cardiometabolic Status in Childhood Acute Lymphoblastic LeukemiaWithdrawnNCT01688752
- A Study of Venetoclax in Combination With Obinutuzumab in Participants With Chronic Lymphocytic LeukemiaCompletedNCT01685892Phase 1
- A Phase 1b Study Evaluating the Safety and Tolerability of ABT-199 in Combination With Rituximab in Subjects With Relapsed Chronic Lymphocytic Leukemia and Small Lymphocytic LymphomaCompletedNCT01682616Phase 1
- Trial of Pentostatin Plus Cyclophosphamide With Ofatumumab (PCO) in Older Patients With Chronic Lymphocytic LeukemiaCompletedNCT01681563Phase 2
- Pharmacogenetically Based Dosing of Thiopurines in Childhood Acute Lymphoblastic LeukemiaCompletedNCT01678508
- A Trial Looking at Ofatumumab for People With Chronic Lymphocytic Leukaemia Who Cannot Have More Intensive TreatmentStatus unknownNCT01678430Phase 3
- A Study of Venetoclax in Combination With Bendamustine + Rituximab or Bendamustine + Obinutuzumab in Participants With Relapsed/Refractory or Previously Untreated Chronic Lymphocytic Leukemia (CLL)CompletedNCT01671904Phase 1
- Trial of FFP+HDMP+Rituximab for Ultra-high Risk Chronic Lymphocytic LeukemiaStatus unknownNCT01670812Phase 3
- Nilotinib and Combination Chemotherapy in Treating Patients With Newly Diagnosed Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia or Blastic Phase Chronic Myelogenous LeukemiaWithdrawnNCT01670084Phase 2
- Phase I Study of Milatuzumab for Graft Versus Host DiseaseTerminatedNCT01663766Phase 1
- A Phase 2, Single-Arm, Open-Label Study Evaluating the Efficacy and Safety of Single Agent GS 1101 (CAL 101) as Therapy for Previously Treated Chronic Lymphocytic LeukemiaWithdrawnNCT01659047Phase 2
- Methoxyamine and Fludarabine Phosphate in Treating Patients With Relapsed or Refractory Hematologic MalignanciesCompletedNCT01658319Phase 1
- Pilot Study Of Sirolimus Plus Multiagent Chemotherapy For Relapsed/Refractory Acute Lymphoblastic Leukemia/LymphomaTerminatedNCT01658007Early Phase 1
- Bendamustine Hydrochloride Injection for Previously Untreated Chronic Lymphocytic LeukemiaStatus unknownNCT01657955Phase 3
- CD19-specific T-cell for Chronic Lymphocytic Leukemia (CLL)CompletedNCT01653717Phase 1
- Studying Genes in Samples From Younger Patients With Acute Lymphoblastic LeukemiaStatus unknownNCT01653613
- Single or Double Donor Umbilical Cord Blood Transplant in Treating Patients With High-Risk Hematologic MalignanciesWithdrawnNCT01652014Phase 2
- A Study of Dinaciclib in Combination With Rituximab in Participants With Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma (P07974)CompletedNCT01650727Phase 1
- Bendamustine in Acute Lymphoblastic Leukemia/Lymphoma (ALL)WithdrawnNCT01649622Phase 2
- Phase 1b Safety and Efficacy Study of TRU-016TerminatedNCT01644253Phase 1
- Dasatinib for Immune Modulation After Donor Stem Cell Transplant for Hematologic MalignanciesTerminatedNCT01643603Phase 1
- Phase II Front-line Ponatinib in Adult Philadelphia+/BCR-ABL+ Acute Lymphoblastic Leukemia.CompletedNCT01641107Phase 2
- Romidepsin in Treating Patients With Lymphoma, Chronic Lymphocytic Leukemia, or Solid Tumors With Liver DysfunctionCompletedNCT01638533Phase 1
- Inducible Regulatory T Cells (iTregs) in Non-Myeloablative Sibling Donor Peripheral Blood Stem Cell TransplantationCompletedNCT01634217Phase 1
- A Phase II Study of AT7519M, a CDK Inhibitor, in Patients With Relapsed and/or Refractory Chronic Lymphocytic LeukemiaCompletedNCT01627054Phase 2